Imipenem/Cilastatin versus Cefepime as Empiric Monotherapy for Fever in Neutropenic Patients after ematopoietic Stem Cell Transplantation

Objective: To evaluate the potential advantages of imipenem/cilastatin in control of fever in neutro-penic HSCT recipients.Patients and Method: In this single-center study, 111 consecutive febrile episodes in 104 neutropenic HSCT recipients with a mean age of 26 years were randomized to treatment ei...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: C Kani, A Mousavi, M Iravani, K Alimoghaddam, B Bahar, M Jahani, A Ghavamzadeh
Формат: Artigo
Язык:Inglês
Опубликовано: Tehran University of Medical Sciences 2005-06-01
Серии:International Journal of Hematology-Oncology and Stem Cell Research
Предметы:
Febrile neutropenia
Monotherapy Hematopoietic
stem cell transplantation
Randomized trial
Online-ссылка:https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/189
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы